Investments

3 Months Ended

Mar. 31, 2022

Investments [Abstract]

Investments

Investments

The Company holds several investments in and loans to non-consolidated entities which are included in Other assets in the condensed consolidated balance sheet. Equity method investments were $87.1 million at March 31, 2022 and $93.7 million at December 31, 2021.

Marketable Equity Securities

The Company classifies publicly traded investments with readily determinable fair values that are not accounted for under the equity method as marketable equity securities. Marketable equity securities are recorded at cost and adjusted to fair value at each reporting period. The changes in fair value between measurement dates are recorded in miscellaneous, net in the condensed consolidated statement of income. Investments in marketable equity securities were $10.1 million at March 31, 2022 and $5.8 million at December 31, 2021. There were $4.3 million unrealized gains and $5.4 million realized losses on marketable equity securities for the three months ended March 31, 2022 and 2021, respectively, included in miscellaneous, net in the condensed consolidated statement of income.

Non-marketable Equity Securities

The Company classifies investments without readily determinable fair values that are not accounted for under the equity method as non- marketable equity securities. Investments in non-marketable equity securities were $37.7 million at March 31, 2022 and December 31, 2021. The changes in value, if any, are recorded in miscellaneous, net in the condensed consolidated statement of income.